Literature DB >> 19834583

Characterization of Molecular Markers Indicative of Cervical Cancer Progression.

Hilal Arnouk1, Mark A Merkley, Robert H Podolsky, Hubert Stöppler, Carlos Santos, Manuel Alvarez, Julio Mariategui, Daron Ferris, Jeffrey R Lee, William S Dynan.   

Abstract

Cervical cancer originates with human papillomavirus (HPV) infection and progresses via histologically-defined premalignant stages. Here we compare normal cervical epithelium and patient-matched high grade squamous intraepithelial lesions (HSIL) with cervical carcinoma tissue from the same patient population (n=10 per group). Specimens were analyzed by combined laser capture microdissection and 2D-DIGE. Significant expression changes were seen with 53 spots resulting in identification of 23 unique proteins at the molecular level. These include eight that uniquely distinguish normal epithelium and HSIL and four that uniquely distinguish HSIL and carcinoma. In addition, one protein, cornulin, distinguishes all three states. Other identified proteins included differentiation markers, oncogene DJ-1, serpins, stress and interferon-responsive proteins, detoxifying enzymes, and serum transporters. A literature review, performed for all identified proteins, allowed most changes to be assigned to one of three causes: direct or indirect HPV oncoprotein interactions, growth selection during latency, or interactions in the lesion microenvironment. Selected findings were confirmed by immunohistochemistry using either frozen sections from the same cohort or formalin fixed paraffin embedded samples from a tissue microarray. Novel markers described here have potential applications for increasing the predictive value of current screening methods.

Entities:  

Year:  2009        PMID: 19834583      PMCID: PMC2761690          DOI: 10.1002/prca.200800068

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  55 in total

1.  Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.

Authors:  Freddie Bray; Anja H Loos; Peter McCarron; Elizabete Weiderpass; Mark Arbyn; Henrik Møller; Matti Hakama; D Max Parkin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-03       Impact factor: 4.254

2.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

3.  Proteomic analysis of progressive factors in uterine cervical cancer.

Authors:  Yoon Pyo Choi; Suki Kang; Sunghee Hong; Xianhe Xie; Nam Hoon Cho
Journal:  Proteomics       Date:  2005-04       Impact factor: 3.984

4.  DJ-1, a novel regulator of the tumor suppressor PTEN.

Authors:  Raymond H Kim; Malte Peters; YingJu Jang; Wei Shi; Melania Pintilie; Graham C Fletcher; Carmela DeLuca; Jennifer Liepa; Lily Zhou; Bryan Snow; Richard C Binari; Armen S Manoukian; Mark R Bray; Fei-Fei Liu; Ming-Sound Tsao; Tak W Mak
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

5.  AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation.

Authors:  Ryan F L O'Shaughnessy; Jonathan C Welti; James C Cooke; Ariel A Avilion; Bobby Monks; Morris J Birnbaum; Carolyn Byrne
Journal:  J Biol Chem       Date:  2007-04-17       Impact factor: 5.157

6.  Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.

Authors:  F Le Naour; D E Misek; M C Krause; L Deneux; T J Giordano; S Scholl; S M Hanash
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

7.  DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras.

Authors:  D Nagakubo; T Taira; H Kitaura; M Ikeda; K Tamai; S M Iguchi-Ariga; H Ariga
Journal:  Biochem Biophys Res Commun       Date:  1997-02-13       Impact factor: 3.575

8.  Proteomic signature of human cancer cells.

Authors:  Masahiro Seike; Tadashi Kondo; Kazuyasu Fujii; Tesshi Yamada; Akihiko Gemma; Shoji Kudoh; Setsuo Hirohashi
Journal:  Proteomics       Date:  2004-09       Impact factor: 3.984

9.  Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma.

Authors:  Ben Davidson; Rivka Hadar; Anat Schlossberg; Tamar Sternlicht; Ana Slipicevic; Martina Skrede; Björn Risberg; Vivi Ann Flørenes; Juri Kopolovic; Reuven Reich
Journal:  Hum Pathol       Date:  2007-10-18       Impact factor: 3.466

10.  Proteomic analysis of high-grade dysplastic cervical cells obtained from ThinPrep slides using laser capture microdissection and mass spectrometry.

Authors:  Ye Gu; Shiaw-Lin Wu; Jane L Meyer; William S Hancock; Lawrence J Burg; James Linder; David W Hanlon; Barry L Karger
Journal:  J Proteome Res       Date:  2007-09-29       Impact factor: 4.466

View more
  20 in total

Review 1.  The Promise of Proteomics in the Study of Oncogenic Viruses.

Authors:  Alison A McBride
Journal:  Mol Cell Proteomics       Date:  2017-01-19       Impact factor: 5.911

2.  Expression Profiling of Hspb1 and Tp53 Genes through RT-qPCR in Different Cancer Types of Canis familiaris.

Authors:  Rashid Saif; Ali Raza Awan; Muhammad Tayyab; Masroor Ellahi Babar; Asim Khalid Mahmood; Asim Khalid Mahmood; Zia Ullah; Saeeda Zia; Muhammad Wasim
Journal:  Iran J Biotechnol       Date:  2017-09-27       Impact factor: 1.671

3.  DJ-1: a promising marker in metastatic uveal melanoma.

Authors:  Li-Li Chen; Jian-Jun Tian; Liang Su; Yan Jing; Shi-Cai Zhang; Hong-Xing Zhang; Xiao-Qing Wang; Cheng-Bao Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-17       Impact factor: 4.553

4.  Chaperon-like Activation of Serum-Inducible Tryptophanyl-tRNA Synthetase Phosphorylation through Refolding as a Tool for Analysis of Clinical Samples.

Authors:  Elena L Paley
Journal:  Transl Oncol       Date:  2011-12-01       Impact factor: 4.243

5.  2D-DIGE proteomic characterization of head and neck squamous cell carcinoma.

Authors:  Mark A Merkley; Paul M Weinberger; Lana L Jackson; Robert H Podolsky; Jeffrey R Lee; William S Dynan
Journal:  Otolaryngol Head Neck Surg       Date:  2009-11       Impact factor: 3.497

6.  Gelsolin and ceruloplasmin as potential predictive biomarkers for cervical cancer by 2D-DIGE proteomics analysis.

Authors:  Ilambarthi Lokamani; Mee-Lee Looi; Siti Aishah Md Ali; Ahmad Zailani Hatta Mohd Dali; Muhammad Azrif Ahmad Annuar; Rahman Jamal
Journal:  Pathol Oncol Res       Date:  2013-08-08       Impact factor: 3.201

7.  Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer.

Authors:  Ying Lin; Phillip J Buckhaults; Jeffrey R Lee; Hairong Xiong; Christopher Farrell; Robert H Podolsky; Robert R Schade; William S Dynan
Journal:  Neoplasia       Date:  2009-09       Impact factor: 5.715

8.  Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues.

Authors:  Federico De Marco; Elona Bucaj; Cesira Foppoli; Ada Fiorini; Carla Blarzino; Kozeta Filipi; Alessandra Giorgi; Maria Eugenia Schininà; Fabio Di Domenico; Raffaella Coccia; D Allan Butterfield; Marzia Perluigi
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

9.  Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies.

Authors:  Kai-Erik Uleberg; Ane Cecilie Munk; Cato Brede; Einar Gudlaugsson; Bianca van Diermen; Ivar Skaland; Anais Malpica; Emiel Am Janssen; Anne Hjelle; Jan Pa Baak
Journal:  Proteome Sci       Date:  2011-06-28       Impact factor: 2.480

10.  Large-scale analysis of protein expression changes in human keratinocytes immortalized by human papilloma virus type 16 E6 and E7 oncogenes.

Authors:  Mark A Merkley; Ellen Hildebrandt; Robert H Podolsky; Hilal Arnouk; Daron G Ferris; William S Dynan; Hubert Stöppler
Journal:  Proteome Sci       Date:  2009-08-23       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.